OMB.report

Federal forms, ICRs, and supporting documents

Information Collection

[NCHHSTP] Centers for Disease Control and Prevention Ending the HIV Epidemic in the United States: Performance Measures (carryover to 2023-2025)

IC 258123 under ICR 202508-0920-003 · OMB 0920-1282.

Documents and Forms
Document Name
Document Type
Form and Instruction
Form and Instruction
Form and Instruction
Form and Instruction
Form and Instruction
Form and Instruction
Form and Instruction
IC Document
IC Document
Information Collection (IC) Details

View Information Collection (IC)

[NCHHSTP] Centers for Disease Control and Prevention Ending the HIV Epidemic in the United States: Performance Measures (carryover to 2023-2025) 0920-21EA
 
Unchanged
 
Voluntary
 

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Form and Instruction None PS20-2010 and PS20-2004 Indicators Reporting Tables Att 1_PS20-2010_PS20-2004 Indicators Reporting Tables 5-13-2021_DHAP_DSTDP_Final.xlsx Yes Yes Fillable Fileable
Form and Instruction None PS20-2010 and PS20-2004 Technical Specifications Att 2_PS20-2010_PS20-2004 Technical Specifications 5-13-2021_DHAP_DSTDP_Final.xlsx Yes Yes Fillable Fileable

Health Illness Prevention

 

183 0
   
Individuals or Households
 
   100 %

  Requested Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 366 0 0 0 0 366
Annual IC Time Burden (Hours) 7,980 0 0 0 0 7,980
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
GENIC Request Template: PS20-2010 and PS20-2004 (carryover 2023-2025) PPEO GenIC RequestTemplate - PS20-2010_PS20-2004_2023-2025.docx 01/27/2023
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.
Something went wrong when downloading this file. If you have any questions, please send an email to [email protected].